Hengrui Pharma Appoints Tian Fei as New Board Secretary
Stock News
Aug 19
Hengrui Pharma (01276) has announced a key executive change, with the appointment of Tian Fei as the company's new Board Secretary.
The decision was formally ratified during the fourth meeting of the tenth Board of Directors, held on August 19, 2026. The move followed a nomination by the company's Chairman and subsequent approval by the Board's Nomination Committee.
The appointment was confirmed through the board's deliberation and passage of the "Proposal on the Change of the Company's Board Secretary." With this resolution, Tian Fei officially assumes the role, succeeding in the position as part of the company's ongoing corporate governance enhancements.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.